Using high density EEG to assess TMS treatment in patients with schizophrenia

dc.contributorHáskólinn í Reykjavíken_US
dc.contributorReykjavik Universityen_US
dc.contributor.authorMarcu, Sara
dc.contributor.authorPegolo, Elena
dc.contributor.authorÍvarsson, Eysteinn
dc.contributor.authorJónasson, Aron Dalin
dc.contributor.authorJónasson, Viktor
dc.contributor.authorAubonnet, Romain
dc.contributor.authorGargiulo, Paolo
dc.contributor.authorBanea, Ovidiu Constantin
dc.contributor.departmentVerkfræðideild (HR)en_US
dc.contributor.departmentDepartment of Engineering (RU)en_US
dc.contributor.schoolTæknisvið (HR)en_US
dc.contributor.schoolSchool of Technology (RU)en_US
dc.date.accessioned2021-02-05T15:06:50Z
dc.date.available2021-02-05T15:06:50Z
dc.date.issued2020-04-01
dc.descriptionPublisher's version (útgefin grein)en_US
dc.description.abstractWe present preliminary results from the ongoing study entitled "Icelandic AVH-TMS" which aim is to study the effectiveness of repetitive transcranial magnetic stimulation (rTMS) treatment for patients with schizophrenia and with persistent auditory verbal hallucinations (AVH) using symptoms and psychometric scales and high-density EEG system (256 channels). The aim of the present work was to describe cortical topography of the auditory evoked responses like P50 and N100-P300 complex in healthy participants and patients with schizophrenia and to define a robust methodology of signal quantification using dense-array EEG. Preliminary data is shown for three healthy participants and three patients in baseline conditions and for two patients we show the results recorded before and after 10 days rTMS treatment. Our results show differences in sensory gating (P50 suppresion) and a stronger N100-P300 response to rare audio stimulus after the treatment. Moreover we show the value of assessing brain electrical activity from high-density EEG (256 channels) analyzing the results in different regions of interest. However, it is premature and hazardous to assume that rTMS treatment effectiveness in patients with AVH can be assessed using P50 suppression ratio.en_US
dc.description.version"Peer Reviewed"en_US
dc.format.extent134-138en_US
dc.identifier.citationMarcu, S., Pegolo, E., Ivarsson, E., Jonasson, A. D., Jonasson, V. D., Aubonnet, R., Gargiulo, P., & Banea, O. C. (2020). Using high density EEG to assess TMS treatment in patients with schizophrenia. European Journal of Translational Myology, 30(1), 134–138. https://doi.org/10.4081/ejtm.2019.8903en_US
dc.identifier.doidoi.org/10.4081/ejtm.2019.8903
dc.identifier.issn2037-7452
dc.identifier.issn2037-7460 (eISSN)
dc.identifier.urihttps://hdl.handle.net/20.500.11815/2454
dc.language.isoenen_US
dc.publisherPAGEPress Publicationsen_US
dc.relation.ispartofseriesEuropean Journal of Translational Myology;30(1)
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectTranscranial magnetic stimulationen_US
dc.subjectSchizophreniaen_US
dc.subjectHigh density EEGen_US
dc.subjectElectroencephalographyen_US
dc.subjectP50en_US
dc.subjectP300en_US
dc.subjectGeðklofien_US
dc.subjectHeilastarfsemien_US
dc.subjectHeilariten_US
dc.subjectBiomedical engineeringen_US
dc.titleUsing high density EEG to assess TMS treatment in patients with schizophreniaen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dcterms.licenseThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License (CC BY-NC 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.en_US

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Hleð...
Thumbnail Image
Nafn:
8903-Article Text-45683-1-10-20200326.pdf
Stærð:
328.57 KB
Snið:
Adobe Portable Document Format
Description:
Publisher's version (útgefin grein)

Undirflokkur